New drug shows promise in shrinking advanced tumors
NCT ID NCT02908906
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 24 times
Summary
This study tests an experimental drug called JNJ-63723283, which helps the immune system fight cancer. It is for people with advanced cancers like lung, melanoma, bladder, and others that have not responded to standard treatments. The goal is to find the best dose and see if the drug can shrink tumors or slow cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
St Louis, Missouri, United States
-
Study site
Pittsburgh, Pennsylvania, United States
-
Study site
Chisinau, Moldova
-
Study site
Bialystok, Poland
-
Study site
Warsaw, Poland
-
Study site
Moscow, Russia
-
Study site
Pyatigorsk, Russia
-
Study site
Saint Petersburg, Russia
-
Study site
Badalona, Spain
-
Study site
Barcelona, Spain
-
Study site
Madrid, Spain
-
Study site
Málaga, Spain
-
Study site
Pamplona, Spain
-
Study site
Seville, Spain
-
Study site
Valencia, Spain
-
Study site
Gothenburg, Sweden
-
Study site
Glasgow, United Kingdom
-
Study site
London, United Kingdom
-
Study site
Manchester, United Kingdom
-
Study site
Newcastle upon Tyne, United Kingdom
Conditions
Explore the condition pages connected to this study.